One Stop Systems, Inc. (OSS)
NASDAQ: OSS · Real-Time Price · USD
5.69
+0.22 (4.02%)
Aug 11, 2025, 2:03 PM - Market open
Inozyme Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Revenue | 55.21 | 54.69 | 60.9 | 72.42 | 61.98 | 51.9 | Upgrade |
Revenue Growth (YoY) | 4.65% | -10.18% | -15.91% | 16.84% | 19.44% | -11.00% | Upgrade |
Cost of Revenue | 46.14 | 46.98 | 42.94 | 52.02 | 42.34 | 35.46 | Upgrade |
Gross Profit | 9.07 | 7.72 | 17.95 | 20.4 | 19.64 | 16.43 | Upgrade |
Selling, General & Admin | 17.6 | 16.98 | 15.92 | 14.09 | 13.86 | 12.54 | Upgrade |
Research & Development | 5.08 | 4.1 | 4.33 | 4.74 | 4.03 | 4.32 | Upgrade |
Operating Expenses | 22.68 | 21.08 | 20.25 | 18.83 | 17.89 | 16.86 | Upgrade |
Operating Income | -13.61 | -13.36 | -2.29 | 1.57 | 1.75 | -0.42 | Upgrade |
Interest Expense | -0.05 | -0.07 | -0.12 | -0.16 | -0.53 | -0.55 | Upgrade |
Interest & Investment Income | 0.34 | 0.48 | 0.54 | 0.24 | 0.24 | 0.42 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | 0.05 | -0.01 | -0.02 | 0.04 | -0.04 | Upgrade |
EBT Excluding Unusual Items | -13.33 | -12.91 | -1.87 | 1.62 | 1.5 | -0.6 | Upgrade |
Impairment of Goodwill | - | - | -5.63 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.07 | -0.08 | -0.01 | Upgrade |
Other Unusual Items | - | - | 1.72 | 0.5 | 1.51 | - | Upgrade |
Pretax Income | -13.33 | -12.91 | -5.79 | 2.19 | 2.94 | -0.61 | Upgrade |
Income Tax Expense | 0.66 | 0.73 | 0.93 | 4.42 | 0.61 | -0.6 | Upgrade |
Earnings From Continuing Operations | -13.99 | -13.63 | -6.72 | -2.23 | 2.33 | -0.01 | Upgrade |
Net Income | -13.99 | -13.63 | -6.72 | -2.23 | 2.33 | -0.01 | Upgrade |
Net Income to Common | -13.99 | -13.63 | -6.72 | -2.23 | 2.33 | -0.01 | Upgrade |
Shares Outstanding (Basic) | 21 | 21 | 21 | 20 | 18 | 17 | Upgrade |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 20 | 20 | 17 | Upgrade |
Shares Change (YoY) | 0.99% | 0.47% | 5.70% | 1.16% | 18.12% | 9.00% | Upgrade |
EPS (Basic) | -0.66 | -0.65 | -0.32 | -0.11 | 0.13 | -0.00 | Upgrade |
EPS (Diluted) | -0.66 | -0.65 | -0.32 | -0.11 | 0.12 | -0.00 | Upgrade |
Free Cash Flow | -3.17 | -0.47 | -1.26 | -8.34 | 5.06 | -1.07 | Upgrade |
Free Cash Flow Per Share | -0.15 | -0.02 | -0.06 | -0.42 | 0.26 | -0.07 | Upgrade |
Gross Margin | 16.43% | 14.11% | 29.48% | 28.17% | 31.69% | 31.67% | Upgrade |
Operating Margin | -24.65% | -24.42% | -3.76% | 2.17% | 2.82% | -0.82% | Upgrade |
Profit Margin | -25.34% | -24.93% | -11.03% | -3.08% | 3.76% | -0.01% | Upgrade |
Free Cash Flow Margin | -5.74% | -0.86% | -2.07% | -11.51% | 8.16% | -2.06% | Upgrade |
EBITDA | -12.68 | -12.31 | -1.21 | 2.62 | 3.23 | 1.18 | Upgrade |
EBITDA Margin | -22.97% | -22.52% | -1.99% | 3.62% | 5.21% | 2.28% | Upgrade |
D&A For EBITDA | 0.93 | 1.04 | 1.08 | 1.05 | 1.48 | 1.61 | Upgrade |
EBIT | -13.61 | -13.36 | -2.29 | 1.57 | 1.75 | -0.42 | Upgrade |
EBIT Margin | -24.65% | -24.42% | -3.76% | 2.17% | 2.82% | -0.82% | Upgrade |
Effective Tax Rate | - | - | - | 201.57% | 20.61% | - | Upgrade |
Advertising Expenses | - | 0.62 | 0.55 | 0.51 | 0.36 | 0.38 | Upgrade |
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.